Short CV/Education and training

  • 1986
    Abitur (A-levels) at the Gymnasium (grammar school) in Markdorf, Germany

  • 1986 – 1991
    Studied biology at the University of Konstanz, Germany

  • 1990 – 1991
    Wrote Diplom thesis under the Chair for biological chemistry, University of Konstanz

  • 1991
    Diplom degree in biology

  • 1991 – 1993
    Doctoral studies under the Chair for biological chemistry, University of Konstanz

  • 1992 – 1995
    Research associate in the biochemical and experimental section of the II Department of Surgery at the University of Cologne, Germany

  • 1993
    Doctor of Natural Science (Dr rer. nat.)

  • 1995 – 2001
    C1 research associate in the Medizinische Klinik III (medical clinic), Cardiology, Goethe University Frankfurt

  • Since 1997
    Head of the division of Molecular Cardiology at Goethe University Frankfurt

  • 1998
    Habilitation (postdoctoral qualification) in experimental medicine

  • 2001
    Appointed University professor of molecular cardiology (C3 professorship with tenure)

  • 2005
    Visiting Professor, Baylor College of Medicine, Houston, USA

  • Since 2006
    Visiting Professor, New York Medical College, USA

  • 2007
    Edmond Hustinx Chair, University of Maastricht, Netherlands

  • Since 2008
    W3 professor, director of the Director of the Institute of Cardiovascular Regeneration, Centre for Molecular Medicine, Goethe University Frankfurt

  • 2008
    Appointed to the Deutscher Ethikrat (German Ethical Committee) by the president of the German Bundestag

Selected publications

  • Dimmeler, S. et al.: Activation of the nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation. In: Nature 399, 1999. pp. 601-605.

  • Dimmeler, S. et al.: Suppression of apoptosis by nitric oxide via inhibition of interleukin-1ß-converting enzyme (ICE)-like and cysteine protease protein (CPP-32)-like proteases. In: J. Exp. Med 185, 1997. pp. 601-607.

  • Dimmeler, S. et al.: HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the PI3K/Akt pathway. In: J Clin Invest 108, 2001. pp. 391-397.

  • Assmus, B. et al.: Transplantation of Progenitor Cells and Re-generation Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). In: Circulation 106, 202. pp. 3009-3017.

  • Haendeler, J. et al.: Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. In: Nature Cell Biology 2002. pp. 743-749.

  • Aicher, A. et al.: Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. In: Nature Medicine 9, 2003. pp. 1370-1376.

  • Badorff, C., Dimmeler, S.: NO balance: regulation of the cytoskeleton in congestive heart failure by nitric oxide (Editorial). In: Circulation 107, 2003. pp. 1348-1349.

  • Chavakis, E. et al.: Role of ß2-integrins for homing and neovascularization capacity of endothelial progenitor cells. In: J Exp Med 201, 2005. pp. 63-72.

  • Urbich, C. et al.: Cathepsin L is required for endothelial progenitor cell-induced neovascularization. In: Nat Med 11, 2005. pp. 206-213.

  • Rössig, L. et al.: Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of pro-genitor cells. In: J Exp Med 201, 2005. pp. 1825-1835.

  • Sasaki, K. et al.: Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. In: Proc Natl Acad Sci USA 103, 2006. pp. 14537-14541.

  • Assmus, B. et al.: Transcoronary transplanta-tion of progenitor cells after myocardial infarction. In: N Engl J Med 355, 2006. pp. 1222-1232.

  • Schächinger, V. et al.: Intra-coronary bone marrow-derived progenitor cells in acute myocardial infarction. In: N Engl J Med 355, 2006. pp. 1210-1221.

Selected projects

  • German Research Foundation (DFG):

  • Transregional Collaborative Research Centre SFB/TR 23

  • Excellence Cluster Cardio-Pulmonary System (ECCPS)

  • Collaborative Research Centre SFB 834

  • European Union (EU):

  • Integrated Project European Union (EU) Integrated Project Angioscaff, Endostem

  • Leducq Foundation Transatlantic Network of Excellence for Cardiac Regeneration

  • European Research Council (ERC)

Membership in scientific bodies/juries

  • Member of the German Cardiac Society – Heart and Circulation Research

  • Member of the German Society for Biochemistry and Molecular Biology (GBM)

  • German Society of Stemcell Research

  • Fellow of the American Heart Association

Member of the editorial board of the following journals:

  • Journal of Clinical Investigation, since 2005

  • Arteriosclerosis Thrombosis Vascular Biology (ATVB), since 2001

  • Basic Research in Cardiology, since 2001

  • Circulation, since 2001

  • Circulation Research, since 2000

Media coverage

Additional qualifications

  • Patents / Patent applications:

  • sCD40L as biochemical marker in cardiovascular disease (Heeschen/Zeiher/Hamm/Dimmeler) (DE 102 53 525.6, 16.11.06)

  • Circulating endothelial cells as diagnostic tool to assess cardiovascular disease progression (Rössig/Zeiher/Dimmeler) (PCT/EP03/12853, 17.11.03, WO 2004/046718 A1, 03.06.04)

  • Placental growth factor, a marker of vascular inflammation, as a diagnostic tool for patients with cardiovascular disease, as a tool to aid in the selection and as a target for the treatment of atherosclerotic disease (Heeschen/Dimmeler/Zeiher) (DE 103 16 059.0, 08.04.03)

  • Chemokine-induced cell migration, a marker for the functional activity of stem and progenitor cells, as a diagnostic tool for patients with cardiovascular disease, as a tool to aid in the selection for patients suitable for autologous cell therapy and as a target for the treatment of atherosclerotic disease (Heeschen/Zeiher/Dimmeler) (DE 103 47 436.6, 13.10.03)

  • Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases – enhanced expression of endothelial nitric oxide synthase using C2431 as a therapeutic tool to enhance stem/progenitor cell function prior to cell therapy for tissue regeneration and tissue neovascularisation (in cooperation with Aventis, Frankfurt) (Dimmeler/Zeiher/Heeschen)

  • Shock wave pre-treatment as a therapeutic tool for targeted recruitment of stem/progenitor cell (in cooperation with Dornier, Munich) (Dimmeler/Zeiher/Heeschen/Aicher)

  • Method for the promotion of angiogenesis, vascularisation, or vascular repair or for the inhibition of tumour angiogenesis (miR-92) (Dimmeler/Zeiher/Kühbacher/Urbich) (DE 102 0007052114.8 30.10.2007)


You can only see the contact information of the academics in the database if you are a registered user of AcademiaNet.
Please register here


  1. Read what our members say about AcademiaNet.

Follow us

No more excuses!

  1. Please download the brochure "No more excuses" and read more about female experts in Europe, and about AcademiaNet.

Similar profiles

  1. Prof. Lital Alfonta

    Biological and related sciences , Physical sciences, Bioelectrochemistry, Synthetic Biology, Chemical Biology

  2. PhD Mar Albà

    Biological and related sciences , Evolution, genomics, bioinformatics

  3. Prof. Dr. Amparo Acker-Palmer

    Biological and related sciences , Health, Cell Biology, Cellular and Molecular Neuroscience, Vascular Biology, Tumour Biology

  4. PhD Sonja Aits

    Biological and related sciences , cell biology, molecular biology, biomedicine



  1. Stefanie Dimmeler Receives ERC Grant

    Professsor Stefanie Dimmeler gets the prestigious "Advanced Investigator Grant" from the European Research Council ERC for her pioneering research on non-coding RNAs. The grant is worth 2,5 million Euros for five years.